Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The crystals floating down in this beaker of ethanol are made from a testosterone analog. Leah Lowder, a Ph.D. student at Dartmouth University who conducted this research in the lab of Sridhar Varadarajan at the University of North Carolina, Wilmington, synthesized the molecule as one piece of a potential anticancer agent. This larger compound works in three stages, represented by three sections of the structure above. First, the testosterone analog targets cancer cells by binding to androgen receptor, a protein that is over-expressed on the outside of some types of cancer cells’ nuclei. The androgen receptor tows the molecule into the nucleus, where another part of the agent can bind to certain regions of the cell’s DNA. Then the molecule’s DNA-methylating component attaches a methyl group to an adenine base, thus damaging the DNA and potentially killing the cancer cell.
Do science. Take pictures. Win money. Enter our photo contest here.
Related C&EN Content:
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter